Epidemiology of chronic renal failure in Spain;Epidemiología de la enfermedad renal crónica en España

Nefrologia

Volumn 23, Issue 6, 2003, Pages 475-477

  De Francisco, A L M ^a   Otero, A ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Complexo Hospitalario de Ourense ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIALYSIS; DIETARY INTAKE; DISEASE SEVERITY; ECONOMIC ASPECT; EDITORIAL; HUMAN; INCIDENCE; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; PATHOLOGY; PREVALENCE; SPAIN; CHRONIC DISEASE; LIVER FAILURE;

CHRONIC DISEASE; HUMANS; LIVER FAILURE; SPAIN;

EID: 3242886596     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Comité de Registro de la SEN: Informe de Diálisis y Trasplante de la Sociedad Española de Nefrología y Registros Autonómicos correspondientes al año 1999. Nefrología XXI: 246-252, 2001.
2. US Renal Data System 2001: Anual Data Report. Atlas of end - Stage Renal Disease in the United States. Bethesda-MD National Institute of Healt. National Institute of Diabetes and Digestive and Kidney Disease 2001.
3. MacClellan WM, Anson CA, Tuttle E: Functional status and quality of life: predictors or early mortality among patients entering treatment for end stage renal disease J Clin Epidemiol 44: 83-89, 1991.
4. De Oreo PB: Haemodyalisis patient-assessed functional health status predicts continued survival hospitalization and dialysis-attendance compliance. Am J Kidney Dis 30: 204-212, 1997.
5. Evaluación epidemiológica de las Tecnologías de Salud: Informe de la Agencia de Evaluación de las Tecnologías Sanitarias, mayo 1995.
6. Obrador GT, Arora P, Kausz AT, Pereira BJG: Pre-end -stage renal care in the United Sates: a state of disrepair. J Am Soc Nephrol 9: S44-S54, 1998.
7. Obrador GT, Pereira BCJ: Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31: 398-417, 1998.
8. Khan IH, Catto GRD, Edward N, MacLeod AM: Chronic renal failure: factors infuencing nephrology referral. Quart J Med 87: 559-564, 1994.
9. Lameire N, Wauters JP, Teruel JL, Van Biesen W, Vanholder R: An update on the referral pattern of patients with end-stage renal disease. Kidney Int Mayo 80 (Supl.): 27-34, 2002.
10. Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, Perteira BJ: Prevalence, predictors and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10: 1281-1286, 1999.
11. Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM: Can we improve early mortality in patients receiving renal replacement therapy. Kidney Int 57: 2539-2545, 2000.
12. Gorriz JL, Sancho A, Pallardo LM, Amoedo ML, Martín M, Sanz P, Barril G, Selgas R, Salgueira M, Palma A, De la Torre M, Ferreras L: Significado pronóstico de la diálisis programada en pacientes que inician tratamiento sustitutivo renal. Un estudio multicéntrico español. Nefrología XXII (1): 49-59, 2002.
13. Fernández-Fresnedo G, De Francisco ALM, Rodrigo E, Piñera C, Herraez I, Ruiz JC, Arias M: Insuficiencia renal «oculta» por valoración de la función renal mediante la creatinina sérica. Nefrología XXII (2): 144-151, 2002.
14. Cockcroft DW, Gault MH: Prediction of creatinine clearence from serum creatinine. Nephron 16: 31-41, 1976.
15. Duncan L, Heathcote J, Djurdjev O, Levin A: Screaning for renal disease with serum creatinine: who are we missing? Nephrol Dial Transplant 16: 1042-1046, 2001.
16. Ledebo L, Kessler M, Van Viesen W: Initiation of dialysis-opinions from as international survey: report on the Dialisis Opinion Symposium at the ERA-EDTA Congress. Nephrol Dial Transplant 16: 1132-1138, 2001.
17. Kinnel K, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanoski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int 54: 236-242, 1998.
18. Stenvinkel P, Barany P, Heimburger VO, Pecoits-Filho R, Lindholm B: Mortality, malnutrition and atherosclerosis in ESRD: what is the role of interleikin-6? Kidney Int 61 S80: S103-S108, 2002.
19. Memoli BPL, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, Andreaucci M, Rossi G: Role of different dialysis membranes in the release of IL-6 soluble receptor in uremic patiens. Kidney Int 58: 417-424, 2000.
20. Yudkin JS, Kumari M, Humphris SE, Mohamed Ali V: Inflammation, obesity, stress and coronary heart disease is IL-6 the link? Atheroesclerosis 148(2): 209-214, 2000.
21. Zoccali C, Mallunaci F, Finochiaro P: Atherosclerotic renal artery sytenosis: epidemiology, cardiovascular outcomes and clinical prediction rules. J Am Soc Nephrol 13: 490, 2002.
22. Mezzano D, Pais EO, Aranda F, Panes O, Downey P, Ortiz M, Tagle González F, Quiroga T, Cáceres MS, Leigthon F, Pereira J: Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60: 1844, 2001.
23. Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E, Nishizawa Y: Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 61: 2187-2192, 2002.
24. Allen DA, Breen C, Yaqood MM, MacDougall IC: Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF alpha. J Invest Med 47 (5): 203, 1999.
25. Foley RN, Parfey PS, Harnet JD: Clinical and echocardiographic disease in patients starting end renal therapy. Kidney Int 47: 186-192, 1997.
26. London G: Cardiovascular Disease in Chronic Renal Failure: Pathophysiologic Aspects. Seminar in Dialysis 16 (2): 85-94, 2003.
27. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O: Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: association with malnutrition, inflammation and cardiovascular disease. Nephrol Dial Transplant 19: 953-960, 2000.
28. Schmit RJ, Domico JR, Sorkin MI, Hobbs G: Early referral and is impact on emergence first dialysis, health care cost and outcome. Am J Kidney Dis 32: 278-283, 1998.
29. Lameire N, Van Biessen W: The pattern of referral of patients with en stage renal disease to the nephrologist: a European survey. Nephrol Dial Transplant 14: S16-23, 1999.
30. Valderrábano F, Horl WH, MacDougall IC, Rossert J, Rutkowski B, Wauters JP: Pre-dialysis survey on anaemia management. Nephrol Dial Transplant 18 (1): 89-100, 2003.
31. Coresh J, Brad CA, Greene T, Eknoyan G, Levey A: Prevalence of chronic kidney disease and decreased kidney function in the adults US population: Third National Health and Nutrition Examination Survey. An J Kidney Dis 41 (1): 1-12, 2003.
32. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (8): 707-709, 2001.
33. Zanchetti A, Hansson L, Dahlof B: Effects of individual risk factor on the incidence of cardiovascular events in the renal treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertension 19(6): 1149-1159, 2001.
34. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6): 461-470, 1999.